FXAIX | USBOX | FXAIX / USBOX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 14 years | 40 years | - |
Gain YTD | 2.013 | 1.915 | 105% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 2500 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 619B | 337M | 183,680% |
Annual Yield % from dividends | 1.31 | 0.31 | 424% |
Returns for 1 year | 27.15 | 9.43 | 288% |
Returns for 3 years | 37.22 | 5.04 | 738% |
Returns for 5 years | 94.81 | 25.30 | 375% |
Returns for 10 years | 222.48 | 38.87 | 572% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MCRTX | 51.08 | 0.74 | +1.47% |
Morgan Stanley Insight R6 | |||
NWAYX | 15.44 | 0.12 | +0.78% |
Nationwide GQG US Quality Eq Eagle | |||
GHAAX | 38.49 | 0.19 | +0.50% |
VanEck Global Resources Fund A | |||
LMGTX | 55.04 | 0.14 | +0.26% |
ClearBridge International Growth C | |||
SHPCX | 13.05 | -0.06 | -0.46% |
Saratoga Health & Biotechnology C |